22HLT06
GenomeMET
Metrology for genomic profiling to support early cancer detection and precision medicine
The project 22HLT06 GenomeMET has received funding from the European Partnership on Metrology, co-financed by the European Union’s Horizon Europe Research and Innovation Programme and by the Participating States.
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or EURAMET. Neither the European Union nor the granting authority can be held responsible for them.
The Project
GenomeMET Work Packages
The GenomeMET project is structured into the following 6 Work Packages:
Develop Reference Measurement Systems (RMS) for validating and ensuring the quality assurance (QA) of genomic profiling IVDs.
News Updates
24-26 June, 2026
At BIOTECH2026 – Frontiers in Italian Biotechnology in Verona, Aurora Schiavon from University of Torino, presented her latest work on Circulating Tumore Cells (CTC) mutational profiling using Parsortix® enrichment and ddPCR, supporting the development of standardized reference materials for liquid biopsy applications.
How can we improve the reliability and reproducibility of liquid biopsy testing?
Her results highlight the potential of an in-cassette lysis workflow for reliable mutation detection in CTC, contributing to improved analytical standardization for future clinical and research applications.
This work is part of the GenomeMET European project, advancing metrology for genomic profiling in early cancer detection and precision medicine.